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Laboratoire d’Imagerie Biome´dicale, Paris, FranceABSTRACT In vitro studies of membrane proteins are of interest only if their structure and function are significantly preserved.
One approach is to insert them into the lipid bilayers of highly viscous cubic phases rendering the insertion and manipulation of
proteins difficult. Less viscous lipid sponge phases are sometimes used, but their relatively narrow domain of existence can be
easily disrupted by protein insertion. We present here a sponge phase consisting of nonionic surfactant bilayers. Its extended
domain of existence and its low viscosity allow easy insertion andmanipulation of membrane proteins. We show for the first time,
to our knowledge, that transmembrane proteins, such as bacteriorhodopsin, sarcoplasmic reticulum Ca2þATPase (SERCA1a),
and its associated enzymes, are fully active in a surfactant phase.INTRODUCTIONTransmembrane proteins are involved in many important
cellular processes, such as solute transport, signal transduc-
tion, and detoxification. In vivo, the cell membrane, mainly
composed of lipids, provides the hydrophobic environment
suitable for maintaining the membrane proteins properly
folded and thus functional. Biophysical studies on mem-
brane protein must therefore provide a mimetic environment
allowing their manipulation in solution as well as maintain-
ing the necessary hydrophobic properties found in vivo in
phospholipid membranes. The use of lipidic mesophases
(such as the cubic phase) has recently gained much popu-
larity with particular emphasis in the membrane protein
crystallization field (1,2). A mesophase is a liquid crystal
phase (3), and the technique of protein crystallization using
a mesophase has been named the in meso method (1,2,4,5).
In 1996 the first reported crystallization of a membrane pro-
tein was that of bacteriorhodopsin in a lipidic cubic phase
(6). Since then, numerous membrane protein structures crys-
tallized in meso have been reported (2,5,7–16). In 2011 the
number of membrane proteins structures determined by the
in meso method and deposited in the Protein Data Bank
(www.mpdb.tcd.ie) (17) stood at 79 (15), and it is increasing
steadily (18–20). The Caffrey group has been particularly
instrumental in advocating the use of mesophases for crys-
tallizing membrane proteins (1,5,12–14,19,21), and hasSubmitted December 12, 2013, and accepted for publication July 7, 2014.
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0006-3495/14/09/1129/7 $2.00recently reported the crystallization of a transmembrane
peptide in meso (22,23). However, to be of interest, the ob-
tained protein crystal structure should be one of a protein
that remains active and despite the successful use of the in
meso crystallization method in membrane structural studies,
some issues regarding its biological/physiological relevance
were raised recently (24). In addition, a recent small angle
x-ray scattering and optical absorption spectroscopy study
has shown that bacteriorhodopsin (BR) inserted into a cubic
monoolein (MO) phase was distorted to the point of being
forced to lose its retinal, which was caused by the mem-
brane-induced saddle splay (25). However, several studies
have shown that lipidic cubic phases are indeed relevant.
In 1995, Hochkoeppler et al. (26) had shown that the mem-
brane proteins as well as the associated soluble proteins of a
bacterial photosynthetic reaction center retained their activ-
ity inside a lipidic cubic phase. More recently, the Caffrey
group has addressed these concerns (27) and has reported
the activity of an integral membrane protein embedded in
the bilayers of a lipidic cubic phase (28).
Although the majority of membrane proteins whose
structures were solved, were crystallized in the lipidic cubic
phase, an increasing number of structures were deduced in
the lipidic sponge (or L3) phase (1,8,10–12,29). Globally,
the sponge phase may be viewed as a molten cubic phase.
Locally, it mimics the lamellar (La) phase, i.e., a stack of
membranes with a characteristic separating distance. From
the topological point of view the L3 phase is a bicontinuous
mesophase consisting of a single curved bilayer that divides
a three-dimensional space in two continuous interpenetrat-
ing but nonconnected spaces filled with aqueous solution
(30). A practical advantage of the sponge phase is that itshttp://dx.doi.org/10.1016/j.bpj.2014.07.016
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phase, as well as that of the lamellar phase, hence is easier
to manipulate. Most cubic and L3 phases are prepared from
MO, a lipid that can form several phases in aqueous solu-
tion: lamellar, cubic, hexagonal, and fluid isotropic/inverse
micellar (31–33). Addition of some polar cosurfactants to
this binary system (i.e., MO/water) results in the formation
of an L3 phase (34,35). Unfortunately, this phase lies in a
very narrow area of the phase diagram, regardless of the
cosurfactant used. This limitation is a real problem as any
addition to the system (e.g., introduction of a membrane
protein) might be sufficient to shift the phase diagram
away from its original position, leading to a possible loss
of the L3 phase. For instance, Conn and colleagues have
demonstrated that the incorporation of the dopamine D2L
receptor and BR within a cubic MO phase affected the
structure of the phase, and this effect was dependent on
the structure of the embedded protein (36,37).
Larger and more stable sponge phase domains can be
reached by replacing lipids by nonionic surfactants (38).
Indeed >20 years ago Strey and colleagues (39) demon-
strated the existence of an L3 phase in the binary system
composed of pentaethylene glycol monododecyl ether
(C12E5), a nonionic surfactant that is routinely used in mem-
brane protein crystallization (40), and water. However this
sponge phase exists only at temperatures higher than 50C,
and very high water contents (>99% wt.), which make this
phase unsuitable for protein studies. Moreover, the addition
of a large quantity of solubilized proteins to the previous
water/C12E5 sponge phase would alter the phase if the addi-
tional detergent used to solubilize the proteins is not C12E5.
We have solved all these problems by adding n-octyl-
b-D-glucopyranoside (b-OG) to the binary water/C12E5
system of Strey et al. (39). This cosurfactant, which is a
nonionic detergent used in membrane protein studies (41),
dramatically lowered the temperature boundary of the
sponge phase in the phase diagram. To the best of our
knowledge this is an unusual L3 phase. The bilayers of the
phase can be swollen by the addition of dodecane (42),
and the intermembrane distance can be adjusted by varying
the water content from 5 to 50 nm (43). Moreover, compared
to the MO/polar solvent/water L3 phase, the viscosity of the
b-OG/C12E5/water L3 phase is much lower, and contrary to
what has been suggested recently (44), the phase exists in a
wide region of the phase diagram as shown below.
In our previous studies (43,45), we showed that several
membrane proteins (MexA, MexB, OprM, OmpA, and
BR) and membrane peptides could be easily inserted into
the bilayer of this sponge phase. Furthermore, we have veri-
fied for several transmembrane proteins that their native
structure is retained in this L3 phase. For the latter, we use
the fact that L3 phase is optically isotropic (unlike La) and
transparent, thus amenable to spectroscopic studies. We
have also shown that the addition of these membrane pro-
teins did not affect the phase properties at least for concen-Biophysical Journal 107(5) 1129–1135trations lower than 60 mM (43). Moreover, we would like to
point out that the insertion of membrane proteins into the
phase would result in the addition of protein-bound lipids
to the phase. This does not change the properties of the
phase, as those lipids are tightly bound to proteins and can
thus be considered as an integral component of the lipid-
protein system. The fact that the addition of proteins and
hence protein-bound lipids at concentrations as high as
60 mM did not alter the properties of the phase (43) further
corroborates this point.
It is important to emphasize that in addition to membrane
protein and peptide crystallization (1,5,10,11,22) lipidic
sponge phases have been used in various applications such
as in drug delivery (46,47), in the extraction of polycyclic
aromatic hydrocarbons (48), in the studies of the lateral
diffusion of membrane proteins and peptides (42,45), and
the interactions between transmembrane proteins (43).
However, it is still a matter of debate if transmembrane
proteins retain their activity when inserted into the bilayers
of a surfactant sponge phase, as is the case for the lipidic cu-
bic phase (28). In this article, we show that this is effectively
the case for the transmembrane proteins BR and sarco-
plasmic reticulum Ca2þ ATPase (SERCA1a). This believed
novel fact adds further appeal to the surfactant sponge phase
as a biomimetic medium.MATERIALS AND METHODS
Materials
Sodium chloride, sodium phosphate monobasic and dibasic, and glycerol
were purchased from Sigma-Aldrich (St. Louis, MO). These reagents
were used to make the 100 mM NaCl, 50 mM sodium phosphate, 5%
(v/v) glycerol, pH 7.5 buffer that was complemented with the desired
detergent. SERCA1a was handled in a 100 mM KCl, 50 mM MOPS Tris,
5mM Mg, 1mM Ca2þ, pH 7.5 buffer also from Sigma-Aldrich.
Phosphoenolpyruvate (PEP), pyruvate kinase (PK), lactate dehydroge-
nase (LDH), nicotinamide adenine dinucleotide (NADH), and ATP (diso-
dium salt) were purchased from Sigma-Aldrich.
The nonionic detergents b-OG and Pentaethylene glycol monododecyl
ether (C12E5) were purchased from Affymetrix-Anatrace (Maumee, OH)
and Nikko Chemicals (Tokyo, Japan), respectively.
C12-FITC, a fluorescent probe, was obtained from Life Technologies-
Invitrogen (Grand Island, NY).Sample preparation
Samples were prepared by mixing the required amounts of surfactant
(C12E5), cosurfactant (b-OG), and water (or buffer) into glass vials. The
samples were vortexed, sonicated, and equilibrated at 20C for several
days before characterization of the resultant phases. Cosurfactants were
dissolved in water (or buffer) at a stock concentration of 10% (w/v).Freeze fracture electron microscopy (FFEM)
The microstructures of the samples were studied by FFEM. A drop of the
liquid sample was placed between two small copper holders to form a sand-
wich, which was then quickly plunged into liquid nitrogen to freeze the
sample. The copper holder, with the frozen sample, was transferred into a
Membrane Protein Activity in Surfactant Bilayers 1131homemade cryo fracture apparatus. The sample was fractured under high
vacuum at 160C and right away a thin layer of platinum (2 nm) was
evaporated under a 45 angle and a thick carbon film (20 nm) was deposited
at 90 to reinforce the replica. The sample was warmed to room temperature
under a dry N2 stream. The replicas were washed in CHCl3 to remove any
remaining component of the original sample. Finally, the resulting solid
replica was collected on 400 mesh copper grids, and observed at 200 kV
with a Tecnai G2 FEI transmission electron microscope (FEI France,
Me´rignac, France), the images were recorded with a slow scan EAGLE
camera (FEI France, Me´rignac, France).Protein production, purification, and labeling
with FITC
SERCA1a was prepared from rabbit fast-twitch skeletal muscle following
the protocol described in (49). SERCA1a labeling was adapted from (50)
with the following changes. SR vesicles were suspended to a concentration
of 2 mg/ml into Tricine-Tris pH8 (100 mM), 0.3 M sucrose, 1 mM MgCl2,
0.01 mM Ca2þ. Labeling was performed by incubating the latter with
0.2 mM FITC for 1 h. The reaction was stopped upon a 10 dilution
into ice-cold, FITC-free labeling, buffer. Under such conditions, protein
was labeled with a 1:1 efficiency.
Halobacter halobium cells were grown under illumination at 37C in
a liquid growth medium containing NaCl 4 M, MgSO4 150 mM, trisodium
citrate 10 mM, KCl 30 mM, yeast extract 5 g/L, and peptone 5 g/L. Purple
membrane was purified on a 30–40% (w/v) sucrose gradient (100,000  g
for 17 h). The membrane suspension was solubilized in Tris HCl 20mM,
glycerol 5%, octylglucoside 0.9% for 48 h at 37C. The volume for the
solubilization was set to resuspend the membrane at a 1:5 (w/w) protein/
detergent ratio. The concentration of solubilized BR was estimated using
ε (570 nm) ¼ 54,000 M-1cm1. Solubilized BR was ultracentrifuged
(100,000  g for 200) to get rid of lipids and insolubilized proteins.Protein insertion in the phase
For all the proteins investigated, insertion was performed by simply adding
a required volume of detergent-solubilized protein into the surfactant,
water, cosurfactant system, making sure that the required surfactant/cosur-
factant ratio was maintained.FIGURE 1 Partial phase diagrams of the ternary systems consisting
of C12E5, water, and b-OG as cosurfactant. Each symbol corresponds to
an experimental sample that was investigated at 20C. The lines drawn
on the diagram represent approximate boundaries between the phases.
The black line in the L3 region of the diagram corresponds to the dilution
line that was investigated with the following methods; small angle x-ray
scattering, small angle neutron scattering, FFEM, and FRAPP. Throughout
this black line the L3 phase exists from 6 to 30
C.Protein activity in the phase
BR activity measurements: photocycle measurements were performed with
a pump-probe spectrophotometer (51) in which the probe and pump ashes
are respectively provided by a Panther Optical Parametric Oscillator
(Continuum France S.A.S., Villebon sur Yvette, France) and a Brilliant
frequency-doubled Nd:Yag laser (Quantel, France, Les Ulis, France). The
kinetics of the absorption changes associated with the rise and decay of
intermediates during the photocycle were recorded at 415 nm from 5 ns
to 100 ms after a 5 ns actinic flash.
ATPase activity measurements
Spectrophotometric measurements of ATP hydrolysis by the Ca2þ-ATPase
were performed with an ATP-regenerating coupled enzyme assay originally
described by Pullman and co-workers (52) and subsequently adapted
(53,54). We describe this measurement in more detail in the paragraph
Results and Discussion. The reaction was performed in 100 mL of a medium
containing 50 mM Tes-Tris, pH 7.0, 50 mM KNO3, 7 mM MgCl2, 1 mM
PEP, 0.1 mg/ml PK, 0.1 mg/ml LDH, an initial concentration of
~0.3 mM NADH, 3–6 mg/ml of purified Ca2þ-ATPase and 0.1 mM total
CaCl2. The reaction was monitored through the variation of absorption at
a wavelength of 340 nm using a Biochrom Libra S22 spectrophotometer
(Biochrom, Cambridge, UK).RESULTS AND DISCUSSION
Characterization of the L3 phase
We checked that throughout the black line, drawn on the
diagram of Fig. 1, the L3 phase exists from 6 to 30
C, a
temperature range more suitable for membrane protein
studies than the C12E5/water system. The boundaries be-
tween the L3 phase and the La phase can easily be detected
optically, as the La phase is birefringent, whereas the
sponge phase is isotropic. Moreover, the use of fluores-
cence recovery after pattern photobleaching (FRAPP)
enables us to discern the boundaries of the two isotropic
phases because the lateral diffusion of a fluorescent probe
will vary significantly from one phase to another. The pre-
cision of the drawn boundaries in the diagram does not
exceed 0.002 M.Protein insertion into the surfactant bilayers of a
sponge phase
First of all, we have checked that both proteins are effec-
tively embedded into the bilayers of the b-OG/C12E5/water
sponge phase by performing FRAPP. For each protein
we have observed a single diffusion coefficient (DATPase ¼
1.7 5 0.1 mm/s2 and DBR ¼ 1.2 5 0.2 mm/s2) (Fig. 2)
whose value was indicative of a macromolecule diffusing
in the bilayers of a sponge phase (42,45).
The fact that the proteins are inserted into the bilayers
was further confirmed by freeze fracture electron micro-
scopy (Fig. 3).Biophysical Journal 107(5) 1129–1135
FIGURE 2 Typical decrease of the FRAPP fringes contrast as a function
of time (here for SERCA1a in L3). From the fit of this curve (measured at
an interfringe distance i ¼ 19.4 mm) we obtain a characteristic decay time
t ¼ 5.2 s, which corresponds to a D value of 1.75 0.1 mm/s2. In the inset,
we present the variation of 1/t as a function of (i/2p)2. The linear behavior
indicates the Brownian motion of the protein embedded in the bilayers of L3
phase and the slope of the linear fit leads to the self-diffusion coefficient of
the protein.
FIGURE 3 Freeze fracture electron microscopy of the L3 containing (a)
SERCA1a at 2.5 mM and (b) BR at 5.0 mM. The image represents the mid-
plane of the bilayers of the sponge phase and the spots pointed by the arrows
represent the replica of SERCA and BR proteins embedded in the bilayer.
The stars point out to the region of the phase devoid of proteins.
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We have already observed that BR keeps its overall fold af-
ter being incorporated into the L3 phase, as judged from its
absorbance spectrum (Fig. S1 in the Supporting Material). It
exhibits absorbance maxima at 280 nm and at 554 nm, a spe-
cific signature of the presence of retinal, a cofactor cova-
lently bound to the protein. When the protein denatures
the retinal signal is lost. The functionality of BR can be
monitored from the analysis of the photocycle it undergoes
upon illumination. BR samples prepared in various environ-
ments (purple membrane, b-OG micelles and L3 phase)
were excited at 640 nm by a 5 ns laser flash. Flash-induced
absorption changes were monitored with a time resolution
of 5 ns at various wavelengths. The kinetics of the absorp-
tion changes reflect the appearance and disappearance of
the steps undergone by the protein during its transport cycle.
Each of these steps has specific wavelength maxima: for
instance, 415 nm is a wavelength specific of a key step:
the M1–M2 transconformation where the increase of the
absorbance is due to the deprotonating of the Schiff’s base.
To unambiguously show that the L3 phase does not affect
the activity of the BR, we have focused on the building
of the M intermediate state. Indeed, this step corresponds
to the largest conformational change performed by the pro-
tein, leading to the opening of cytoplasmic channel and
hence to the directionality of proton pumping. It is hence
a relevant indicator of the overall activity of the protein.
As can be seen in the case of the control where the pro-
tein is located in its native membrane (Fig. 4), the time
resolved absorption spectrum is bell-shaped: the absorptionBiophysical Journal 107(5) 1129–1135maximum is attained and then the protein relaxes down to its
initial level. We observe that BR also performs a photocycle
when it is reconstituted in the L3 phase (Fig. 4): the absorp-
tion maximum is reached in ~20 ms, i.e., significantly faster
than in a membrane, and then relaxes back to its initial level,
which is an unambiguous sign that the protein undergoes a
full, genuine cycle. The exact same trend is observed when
the protein is in detergent/b-OG micelles (Fig. 4). The faster
FIGURE 4 Time-resolved absorption of BR at 415 nm dissolved in the
purple membrane (:); b-OG micelles (*); the L3 phase (CBR ¼2.1 mM)
(-); the solution mimicking the intermembrane liquid space (CBR ¼
0.1 mM) (,), see Results and Discussion.
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upon reconstitution into the L3 phase is in agreement with
literature: it has been shown that the M1-M2 step is acceler-
ated in detergent compared to what is observed in membrane
(55). A tentative explanation is that the lateral pressure
induced by the lipidic membrane on the protein is relaxed
when the protein is solubilized and that this flexibility
makes it easier for the protein to undergo its large conforma-
tional change. The same flexibility would be maintained in
the L3 phase.
One can still argue that the BR embedded in bilayers is
inactive and that the observed BR activity is caused by small
amounts of protein located in the liquid solution between the
bilayers. We refuted this hypothesis by performing FRAPP
experiments. Indeed, FRAPP should provide diffusion coef-
ficients of slowly diffusing species, embedded into the sur-
factant bilayers, and rapidly diffusing species, located in the
aqueous solvent between bilayers. Our FRAPP measure-
ments showed only one, slowly diffusing, species corre-
sponding to that of the bilayer-embedded protein. This
however did not rule out the fact that tiny amounts of BR,
undetectable by FRAPP, could still be solubilized in the
aqueous solution and that the solubilized amount could be
sufficient to produce the observed spectra. Thus, to mimic
the activity of potential BR species dissolved in the solution
located between the bilayers of the L3 phase, we have solu-
bilized BR in an aqueous solution of b-OG/C12E5 (both sur-
factants at a concentration below their respective critical
micellar concentration values).The highest BR concentra-
tion undetectable by FRAPP was 0.1 mM, thus correspond-
ing to the maximal amount of hypothetical residual protein
inserted between bilayers. The observed activity is signifi-
cantly lower (Fig. 4) than that observed when the BR, at a
concentration of 2.1 mM, is dissolved in the sponge phase.This confirms that activity observed in phase L3 is due to
the BR incorporated into surfactant bilayers of L3 phase.
SERCA1a activity
SERCA1a is a well-known membrane protein paradigm of
the P-type ATPases. Its catalytic activity has been studied
extensively from both functional and structural points of
view (56,57). Of particular relevance to this work is the
fact that this enzyme is known to be exceedingly sensitive
to the particular detergent used to maintain it in solution
(58). We then investigated the effect of the insertion of
SERCA1a in the sponge phase by use of a coupled enzyme
assay where, as the enzyme hydrolyses ATP and produces a
molecule of ADP, PK catalyzes the dephosphorylation of
PEP, leading to a molecule of pyruvate while, at the same
time, the ADP molecule is reconverted to ATP. This reaction
(so-called ATP regenerating system) allows to keep the
concentration of ATP constant in the medium. In turn, the
pyruvate formed is reduced to lactate by LDH and one mole-
cule of NADH is oxidized into NADþ. Monitoring the
decrease of the optical density at 340 nm, wavelength at
which NADH absorbs, hence makes it possible to estimate
the decrease in the concentration of NADH as a function
of time, a value that is stoichiometrically related to ATP
hydrolysis. The rate of hydrolysis is standardized to the
quantity of proteins and is therefore expressed in micro-
mole ATP hydrolyzed per milligram of protein per minute.
We have reconstituted the SERCA1a into a sponge phase
consisting of C12E5, b-OG, and MOPS-Tris buffer (see
Materials and Methods). After the protein was solubilized
either with b-OG or C12E5, the cognate detergent was added
to reach a C12E5/b-OG ratio (w/w) consistent with the for-
mation of an L3 phase.
The latter detergent mixture was hydrated with a buffer
containing the various enzymes necessary to perform a
coupled-enzyme assay with proteins incorporated in an L3
phase. The activity assay was carried out with an enzyme
concentration equal to that used for the BR activity assay
described previously. Here, we show that the ATPase activ-
ity for the protein incorporated into an L3 phase is equal to
2.5 mmol mg1 min1, a value in the same order of magni-
tude as that reported in C12E8, (octaethylene glycol mono-
dodecyl ether), a detergent known to be the most efficient
at keeping the protein active in solution (53) (Fig. 5).
Indeed, the activity of SERCA1a was previously shown
to be in the range of 4–6 mmol /mg/min. Conversely, we
observe the previously known fact that the protein activity
is poorly maintained in the presence of b-OG (58).
In conclusion, we have shown for the first time, to our
knowledge, that membrane proteins are active in surfactant
bilayers. The L3 phase, obtained by the addition of C12E5
and 10% of b-OG to buffer/water, is a convenient medium
for incorporating membrane proteins into a biomimetic
environment that makes it possible to endeavor into
the investigation of various biophysical and biochemicalBiophysical Journal 107(5) 1129–1135
FIGURE 5 Enzymatic activity of the SERCA1a reconstituted in various
environments. The end product of this coupled-enzyme assay is the oxida-
tion of NADH to NADþ, which is seen as the decrease in absorption at
340 nm (the top panel). In the bottom panel the activity of the enzyme in
the L3 phase is compared to its activity in micellar solutions of either
b-OG (low activity), C12E8 (high activity), or in a medium mimicking the
L3 intermembrane space (I-S, dotted line, low activity). The latter measure-
ment has been performed at an enzyme concentration of 0.1 mM corre-
sponding to the threshold detection by FRAPP. All other measurements
have been performed at 1 mM. ATP: adenosine triphosphate. ADP: adeno-
sine diphosphate. NAD: nicotinamide adenine dinucleotide. PK: pyruvate
kinase. PEP: phosphoenolpyruvic acid.
1134 Rayan et al.parameters, such as the measurement of lateral diffusion
(42,43,45); determination of interaction stoichiometry
(43); or protein crystallization, while preserving the mem-
brane protein activity, even though b-OG is a harsh surfac-
tant when compared to milder surfactants such as DDM,
Cymal-4, and Cymal-5. In addition, our approach remains
valid by replacing b-OG by milder surfactants that do not
destabilize the sponge phase structure.SUPPORTING MATERIAL
One figure is available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(14)00734-6.
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